Inhibition of CSF1R and KIT With Pexidartinib Reduces Inflammatory Signaling and Cell Viability in Endometriosis.
Dunn TN, Cope DI, Tang S, Sirupangi T, Parks SE, Liao Z, Yuan F, Creighton CJ, Masand RP, Alpuing Radilla L, Guan X, Detti L, Monsivais D, Matzuk MM.
Dunn TN, et al. Among authors: cope di.
Endocrinology. 2024 Feb 20;165(4):bqae003. doi: 10.1210/endocr/bqae003.
Endocrinology. 2024.
PMID: 38227801